<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee JS</submitter><funding>National Research Foundation of Korea</funding><pagination>34</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10773012</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a significant medical challenge, with no indisputable pathophysiological mechanism identified to date.&lt;h4>Methods&lt;/h4>Based on clinical clues, we hypothesized that 5-hydroxytryptamine (5-HT) hyperactivation is implicated in the pathogenic causes of ME/CFS and the associated symptoms. We experimentally evaluated this hypothesis in a series of mouse models.&lt;h4>Results&lt;/h4>High-dose selective serotonin reuptake inhibitor (SSRI) treatment induced intra- and extracellular serotonin spillover in the dorsal raphe nuclei of mice. This condition resulted in severe fatigue (rota-rod, fatigue rotating wheel and home-cage activity tests) and ME/CFS-associated symptoms (nest building, plantar and open field test), along w</pubmed_abstract><journal>Journal of translational medicine</journal><pubmed_title>Central 5-HTergic hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like pathophysiology.</pubmed_title><pmcid>PMC10773012</pmcid><funding_grant_id>NRF-2018R1A6A1A03025221</funding_grant_id><pubmed_authors>Lee JS</pubmed_authors><pubmed_authors>Hwang SJ</pubmed_authors><pubmed_authors>Son CG</pubmed_authors><pubmed_authors>Bae SJ</pubmed_authors><pubmed_authors>Kang JY</pubmed_authors><pubmed_authors>Park SY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Central 5-HTergic hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like pathophysiology.</name><description>&lt;h4>Objectives&lt;/h4>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a significant medical challenge, with no indisputable pathophysiological mechanism identified to date.&lt;h4>Methods&lt;/h4>Based on clinical clues, we hypothesized that 5-hydroxytryptamine (5-HT) hyperactivation is implicated in the pathogenic causes of ME/CFS and the associated symptoms. We experimentally evaluated this hypothesis in a series of mouse models.&lt;h4>Results&lt;/h4>High-dose selective serotonin reuptake inhibitor (SSRI) treatment induced intra- and extracellular serotonin spillover in the dorsal raphe nuclei of mice. This condition resulted in severe fatigue (rota-rod, fatigue rotating wheel and home-cage activity tests) and ME/CFS-associated symptoms (nest building, plantar and open field test), along w</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-03-31T10:55:52.536Z</modification><creation>2025-04-06T09:22:45.201Z</creation></dates><accession>S-EPMC10773012</accession><cross_references><pubmed>38191373</pubmed><doi>10.1186/s12967-023-04808-x</doi></cross_references></HashMap>